Oxidronic acid

DB14159ApprovedSmall molecule

Oxidronic acid is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients.

Chemical structure of Oxidronic acid
Primary indication
Oxidronic acid is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients.Curator reviewed · 1 structured indication
Formula / weight
CH6O7P2 · 192.0 g/mol (avg)
First approval
United States, 2007
Also known as
HMD-P · HMDP · Hydroxymethanediphosphonic acid · Oxidronate

Resolves to

Compound
UNII71MR4V32TICAS15468-10-7ChEMBLCHEMBL1615775ChEBI134844
Clinical / RWD
RxNorm1546448
Structure
InChIKeyHJZKOAYDRQLPME-UHFFFAOYSA-NSMILESOC(P(O)(O)=O)P(O)(O)=O

What you can answer from here — as of August 30, 2026

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
7Marketed productsAcross 5 countries and 4 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Oxidronic acid, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In